genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2017
Heptares Therapeutics
Industry News
Heptares, University of Cambridge Launch Research Collaboration
GEN Staff Writer
-
January 31, 2017
0
Industry News
Heptares to Acquire G7 Therapeutics
GEN Staff Writer
-
November 30, 2016
0
Industry News
Teva, Heptares Launch Up-to-$410M+ Migraine Alliance
GEN Staff Writer
-
November 25, 2015
0
Drug Discovery
Research Phase Complete in Heptares/MedImmune Collab
GEN Staff Writer
-
January 23, 2014
0
Drug Discovery
MorphoSys Strikes GCPR Deal with Heptares
GEN Staff Writer
-
February 13, 2013
0
News
GPCRs Targeted in Heptares/Cubist Collab
GEN Staff Writer
-
January 7, 2013
0
Insights
People in the News
GEN Staff Writer
-
December 1, 2012
0
2A Receptor Antagonist for CNS Diseases />
News
Shire Licenses Heptares’ Adenosine A
2A
Receptor Antagonist for CNS Diseases
GEN Staff Writer
-
March 20, 2012
0
Insights
Coupling SPR Increases Value
Kathy Liszewski
-
February 15, 2012
0
News
AstraZeneca Pays Heptares $6.25M to Tap GPCR Expertise for Therapeutic Development
GEN Staff Writer
-
May 31, 2011
0
1
2
Page 1 of 2
Scroll Up
Scroll Up
